» Research at the School of Pharmacy
Research Centers
Facilities
NIH Awards Dr. Miao Zhang $434K for Rare Genetic Disease Research
Zimmermann-Laband syndrome 3 (ZLS3) is a rare genetic disorder characterized by gingival enlargement and intellectual disabilities. Recent research links ZLS3 to mutations in KCa2.3 channels, increasing their calcium ion sensitivity. The study aims to find treatments for the dysfunctional KCa2.3 channels to alleviate ZLS3 symptoms and develop targeted therapeutic interventions.
$2.2M R01 Grant is Awarded to Dr. Ren Ostrom
How do hormones, neurotransmitters, and drugs affect airway smooth muscle cells at a sub-cellular level? By using imaging techniques, the research will elucidate the spatial characteristics and unique signal patterns of G protein-coupled receptors and the relationship between spatial and temporal regulation of contractile proteins by cAMP and calcium signals. This may lead to the development of new drugs targeting signaling compartmentst to improve asthma symptoms.
Dr. Jerika Lam Receives Grant to Continue Search for HIV Prevention Outcomes
Pre-exposure prophylaxis (PrEP) medications are highly effective in limiting the spread of HIV, yet only 18% of persons at risk are prescribed PrEP in the United States. This research will investigatewhat the complex factors are that influence the adoption of pharmacy-based PrEP to improve the utility of this potentially powerful intervention.
Industry Partners
Chapman University School of Pharmacy is proud to partner with industry leaders to strive together in the development and discovery of new treatments and medicines that will improve lives around the globe. Some of our partners are listed below in the drop down.
Interested in becoming a research partner? Contact our Associate Dean for Research and Graduate Programs, Dr. Jennifer Totonchy, for information.
Current Partners
- AJK Biopharmaceutical
- Merck
- Masimo
- Cornerstone
- Zymo
- Amberstone
- Dxome
- Paratek Pharmaceuticals